Figure 1 (Ful0d 0000 01)
Fulvestrant Injection, Solution
Product Images NDC 25021-471
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fulvestrant (NDC 25021-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figur 2e (Ful0d 0000 02)
Figure 3 (Ful0d 0000 03)
Figure 4 (Ful0d 0000 04)
Figure 5 (Ful0d 0000 05)
Structural Formula (Ful0d 0000 06)
Figure 6 (Ful0d 0000 07)
This is a study on Progression Free Survival with Fulvestrant 250mg and 500mg treatment in an ITT Population over a period of 45 months. The chart shows the number at risk at different time points for both treatment groups.*
Figure 7 (Ful0d 0000 08)
Figure 8 (Ful0d 0000 09)
Figure 9 (Ful0d 0000 10)
Figure 10 (Ful0d 0000 11)
Figure 11 (Ful0d 0000 12)
Figure 12 (Ful0d 0000 13)
Figure 13 (Ful0d 0000 14)
Figure 14 (Ful0d 0000 15)
Package Label – Principal Display Panel – Syringe Label (Ful0d 0000 16)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
